Trials
MRD trials
The curated index is a sourced list of studies. Accruing is the live ClinicalTrials.gov recruiting set. DYNAMIC-III is not in the curated index because it is registered in Australia and New Zealand, not with an NCT id.
Recruiting interventional studies whose public record uses ctDNA or MRD to guide treatment, or lists it as a primary endpoint. 110 studies from 454 registry hits. Last synced Nov 14, 2026, 9:51 PM EST.
Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
Washington University School of Medicine · 1 locations · Updated 2026-03-23
NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer
Aarhus University Hospital · 13 locations · Updated 2024-08-14
Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer
Poitiers University Hospital · 1 locations · Updated 2025-12-24
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Memorial Sloan Kettering Cancer Center · 7 locations · Updated 2025-12-18
Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients
Royal Marsden NHS Foundation Trust · 1 locations · Updated 2026-06-29
A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma
University of Rochester · 1 locations · Updated 2026-10-13
Prognostic Value of Measuring CtDNA in a Cohort of Patients With Stage III and IV Upper Aero-digestive Tract (UADT) Cancer , Treated With Curative RADiOtherapy With or Without Concomitant Treatment.
Institut de Cancérologie de Lorraine · 7 locations · Updated 2025-12-24
Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer
University of Chicago · 1 locations · Updated 2025-06-08
Status can change after this sync. The curated list is the other view on this page. Evidence holds the published results.